Resource Hub
Donate Now
Who we are
Our Strategy
Strategy Extension
GPEI Action Plan
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Poliovirus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Access to Vaccines
Containment
Environmental Safeguarding
Gender Mainstreaming
Polio Gender Champions
Integration
Outbreak Preparedness & Response
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Routine Immunization
Supplementary Immunization
Surveillance
Donors & Financing
Financial Resource Requirements
GPEI Budget 2026
GPEI Budget 2025
GPEI Budget 2024
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
News
Media Centre
Take Action
Donate
Who we are
Our Strategy
Strategy Extension
GPEI Action Plan
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Poliovirus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Access to Vaccines
Containment
Environmental Safeguarding
Gender Mainstreaming
Polio Gender Champions
Integration
Outbreak Preparedness & Response
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Routine Immunization
Supplementary Immunization
Surveillance
Donors & Financing
Financial Resource Requirements
GPEI Budget 2026
GPEI Budget 2025
GPEI Budget 2024
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
News
Media Centre
Take Action
Donate
16/01/2025
Polio Vaccine Security Framework
Read More
13/12/2024
Annual Consultation between the GPEI and polio vaccine manufacturers, National Authorities for Containment and National Regulatory Authorities
Read More
23/09/2024
nOPV2 Safety Monitoring Guidance Manual
Read More
11/09/2024
21st Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities
Read More
11/09/2024
20th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities
Read More
11/09/2024
19th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities
Read More
11/09/2024
18th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities
Read More
11/09/2024
17th Consultation with OPV/IPV Manufacturers and National Authorities for Containment
Read More
17/05/2024
IPV request form – Dec 2016
Read More
17/05/2024
Cold chain logistics and vaccine management during SIA – May 2017
Read More
17/05/2024
mOPV2 vaccine request form – January 2021
Read More
17/05/2024
tOPV request form (for tOPV with a VVM on the label)
Read More
17/05/2024
nOPV2 Vaccine Handling
Read More
17/05/2024
nOPV2 Vaccine Management Guidance
Read More
17/05/2024
nOPV2 vaccine request form – January 2024
Read More
17/05/2024
Technical guidance mOPV2 vaccine management, monitoring, removal and disposal – May 2021
Read More
17/05/2024
Global OPV Stockpile Strategy 2022-2026
Read More